Clovis Oncology, Inc. CLVS

• Apparently, I am the ONLY ONE who can spot a

SHAKE OUT

• BUYOUT here would likely bring $9B. That is 90X for those who cant count

• With the POWERFUL drug set Clovis has, it is a NO BRAINER that SNY and BMY are interested

• Looks like a good loading zone to me

• HMMM.. this might shoot STRAIGHT UP

• I also have close to 600k calls for different price points

• I have a .79 avg for 1/4M shares. Long here for 4 months

• For SURE, Pat has been approached by BMY and SNY. Probably in the middle of a bidding WAR with each other over Clovis.

• If Sanofi will pay $1.9B for this:
  graft-versus-host disease drug

What in the HELL do you think a company with MULTIPLE CANCER DRUGS is worth to them ?!!!

• Sanofi is actually in acquisition MODE:

September 2021:
Kadmon Holdings (KDMN) stock is rising higher on Wednesday following news of a deal with Sanofi (SNY) that comes to $1.9 billion.